Clin2
NCT06673602Worth exploringRecruiting

Herbal capsule for memory problems after bleeding stroke

Cognitive ImpairmentIntracerebral Hemorrhage

Treatments studied

Part of Brain & nervous system, Heart & circulation, Mental health clinical trials.

This trial tests a Chinese herbal capsule called Fufang Congrong Yizhi Capsule (FCYC) to see if it can help with memory and thinking problems that start after a bleeding stroke. It is for people who have had robot-assisted surgery for their stroke and also fit a specific pattern in traditional Chinese medicine.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
200 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You had a bleeding stroke (intracerebral hemorrhage) and had brain surgery with a robot to treat it.
  • You have problems with thinking or memory after your stroke (post-stroke cognitive impairment).
  • A traditional Chinese medicine doctor has diagnosed you with a specific pattern: liver and kidney weakness with phlegm and blood stasis blocking your body's pathways.
  • You are 18 years or older.
  • It has been at least 2 weeks since your stroke, and you are awake and able to do thinking tests.
  • You agree to take part in the study and sign a consent form.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07752719Not yet recruiting· Phase 3
Chinese medicine for recent brain bleeding

This trial tests a traditional Chinese medicine (called Angong Niuhuang Wan) for people who have had a bleeding stroke within the last 6 hours. The goal is to see if this medicine helps reduce the damage from the bleed and improves recovery.

NCT07801599Not yet recruiting· Phase 3
Granules versus tea for recent brain bleeding

This trial tests a Chinese herbal medicine in granule form compared to the traditional boiled tea version for people who have recently had bleeding in the brain. The goal is to see if the granules work as well as or better than the usual decoction.

NCT07250035Recruiting· Phase 3
Chinese herb trial for brain bleed linked to amyloid angiopathy

This trial tests a traditional Chinese medicine called Jiedu Huayu to see if it helps people recover from a brain bleed caused by a condition where proteins build up in blood vessel walls (cerebral amyloid angiopathy). The goal is to improve outcomes without surgery.

Beijing
NCT07271732Not yet recruiting
Blood pressure and liver yang capsules for small vessel brain disease

This trial tests whether an herbal capsule called Songling Xuemaikang can help people with brain changes caused by small vessel disease, such as white matter lesions or small strokes. It may improve symptoms like headache or dizziness in people with high blood pressure.

Beijing, Beijing Municipality
NCT06061692Not yet recruiting· Phase 4
Tongxinluo capsule for memory problems linked to small vessel disease

This trial tests whether the herbal capsule Tongxinluo can improve memory and thinking in people with small vessel disease, a condition that affects blood flow in the brain. Participants will receive either the capsule or a placebo (a pill with no active ingredient) for a period of time to see if it helps.

NCT07690020Not yet recruiting
Herbal capsule for recent ischemic stroke recovery

This trial tests whether a Chinese herbal capsule (Getong Tongluo) can improve recovery after a recent ischemic stroke. It may help reduce disability by protecting brain cells and improving blood flow.

Hear when a new Cognitive Impairment trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.